Multimodal Assesment of Alzheimer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorNorwegian University of Science and Technology
About this trial
The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD).
The main questions the study aims to answer are:
1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease?
Participants will undergo:
* Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.
Eligibility criteria
Qualifiers
MCI and AD according to relevant ICD-criterias.
Control cohort is age and gender matched with other cohorts.
Disqualifiers
Uneligibility for any of the planned neuroimagery devices (MRI, EEG)
AD diagnosis before the age of 65 (Early-onset AD).
Brain tumor
Traumtic head injury
Trial design
Treatments tested in this trial
- MRI Scanning
- 64-channel EEG
- Polysomnography
- Blood samples
- Fecal samples
- Cognitive tests
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov